Global Horse Vaccines Market Growth 2023-2029

Global Horse Vaccines Market Growth 2023-2029

The global Horse Vaccines market size is projected to grow from US$ 637.8 million in 2022 to US$ 934.1 million in 2029; it is expected to grow at a CAGR of 5.6% from 2023 to 2029.

United States market for Horse Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Horse Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Horse Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Horse Vaccines players cover Merck Animal Health, Boehringer Ingelheim, Zoetis, Colorado Serum, VetOne, Neogen, Wuhan Chopper Biology Co., Ltd. and Intervacc AB, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

LPI (LP Information)' newest research report, the “Horse Vaccines Industry Forecast” looks at past sales and reviews total world Horse Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Horse Vaccines sales for 2023 through 2029. With Horse Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Horse Vaccines industry.

This Insight Report provides a comprehensive analysis of the global Horse Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Horse Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Horse Vaccines market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Horse Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Horse Vaccines.

This report presents a comprehensive overview, market shares, and growth opportunities of Horse Vaccines market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Rabies Vaccine
Eastern and Western Equine Encephalomyelitis (EEE/WEE) Vaccine
Tetanus Vaccine
West Nile Virus (WNV) Vaccine
Others

Segmentation by application
Adult Horse(>12 Months)
Young Horse(≤12 Months)

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Merck Animal Health
Boehringer Ingelheim
Zoetis
Colorado Serum
VetOne
Neogen
Wuhan Chopper Biology Co., Ltd.
Intervacc AB

Key Questions Addressed in this Report

What is the 10-year outlook for the global Horse Vaccines market?

What factors are driving Horse Vaccines market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Horse Vaccines market opportunities vary by end market size?

How does Horse Vaccines break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.